共 50 条
- [3] Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 2149 - 2155
- [4] Treatment choice in EGFR-mutant non-small-cell lung cancer [J]. LANCET ONCOLOGY, 2017, 18 (11): : 1425 - 1426
- [7] Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer [J]. CURRENT ONCOLOGY, 2018, 25 : S38 - S44
- [8] Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer [J]. LANCET ONCOLOGY, 2018, 19 (03): : E124 - E124
- [9] Targeting MET amplification in EGFR-mutant non-small-cell lung cancer [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (11): : 1068 - 1070
- [10] Minimal residual disease in EGFR-mutant non-small-cell lung cancer [J]. FRONTIERS IN ONCOLOGY, 2022, 12